Dulgar, Ozgecan
Kutuk, Tugce
Eroglu, Zeynep
Article History
First Online: 23 December 2020
Decalarations
:
: No external funding was used in the preparation of this article.
: Ozgecan Dulgar and Tugce Kutuk have no conflicts of interest that are directly relevant to the content of this article. Zeynep Eroglu has served on advisory boards for Array, Novartis, Genentech, Regeneron, Natera, and SunPharma and received research funding from Novartis.
: All authors were involved in the writing and revising of the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.